Fumihiko Urano M.D.

With his training in anatomical and clinical pathology and his research in Pathology and Pediatric Oncology and Medical Genetics, Dr. Urano studied molecular endocrinology and Endoplasmic Reticulum (ER) biology at the New York University Medical Center.

Currently, his main commitment is to find a cure for juvenile diabetes and for the genetic forms of diabetes including type 1 diabetes and Wolfram syndrome using gene based stem cell and diagnostic therapies.

Dr. Urano was included in the American Society for Clinical Investigation in 2011.

Dr. Urano’s research is focused on the development of personalized medicines for juvenile diabetes and the genetic forms of diabetes, especially Wolfram syndrome characterized by type 1 diabetes, optic nerve atrophy and neurodegeneration.

The Uranian team has created gene-based diagnostics for Wolfram syndrome and other forms of juvenile diabetes and is currently developing novel therapies using patients’ skin-derived stem cells.

The team is also developing a method for the regeneration of insulin-producing cells using a trophic factor (a substance produced by the body that guarantees cell survival and also stimulates its growth).

In addition, he also created the regist of patients with the Wolfram Syndrome to identify the biomarkers that regulate the progress of the disease and get to create drugs to structure clinical pathways.


If you want to contact Dr. Fumihiko Urano directly, you can find him at the following addresses:

Samuel E. Schechter Professor of Medicine
Office Location: 8808A Wohl Hospital
660 S. Euclid Ave
Campus Box 8127
St. Louis, MO 63110
Telephone Office: (314) 362-8683
Fax: (314) 382-8265
Cris Brown, Wolfram Syndrome Registry Manager: (314) 362-8684
Email: urano@dom.wustl.edu

Or, alternatively you can directly send an email by filling out the following form.